These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36343537)

  • 61. LC and LC-MS/MS studies for the identification and characterization of degradation products of acebutolol.
    Rakibe U; Tiwari R; Mahajan A; Rane V; Wakte P
    J Pharm Anal; 2018 Dec; 8(6):357-365. PubMed ID: 30595941
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Study of forced degradation behavior of enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay method.
    Bhardwaj SP; Singh S
    J Pharm Biomed Anal; 2008 Jan; 46(1):113-20. PubMed ID: 17964751
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Isolation and characterization of pseudo degradation products of acalabrutinib using ESI-HRMS/MS and NMR: Formation of possible geometrical isomers.
    Panda S; Das M; Kandula RR; Gajjela R; Ravuri NDH; Kumar H; Kalamse S; Mathur A; Roy A; Bagadi M
    J Pharm Biomed Anal; 2023 Feb; 225():115214. PubMed ID: 36621281
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Stress degradation studies on lornoxicam using LC, LC-MS/TOF and LC-MSn.
    Modhave DT; Handa T; Shah RP; Singh S
    J Pharm Biomed Anal; 2011 Nov; 56(3):538-45. PubMed ID: 21757313
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of potential degradation products of brexpiprazole by liquid chromatography/quadrupole-time-of-flight mass spectrometry and nuclear magnetic resonance, and prediction of their physicochemical properties by ADMET Predictor™.
    Kushwah BS; Singh S; Thummar MM; Balhara A; Samanthula G
    Rapid Commun Mass Spectrom; 2023 Jan; 37(1):e9415. PubMed ID: 36226712
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mechanism of capmatinib degradation in stress conditions including degradation product characterization using ultra-high-performance liquid chromatography-quadrupole-time of flight mass spectrometry and stability-indicating analytical method development.
    Bhangare D; Rajput N; Jadav T; Sahu AK; Sengupta P
    Rapid Commun Mass Spectrom; 2023 Jan; 37(1):e9417. PubMed ID: 36226771
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Selective separation and characterization of the stress degradation products of ondansetron hydrochloride by liquid chromatography with quadrupole time-of-flight mass spectrometry.
    Talluri MV; Keshari KK; Kalariya PD; Srinivas R
    J Sep Sci; 2015 May; 38(10):1625-32. PubMed ID: 25727389
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Separation and characterization of related substances of Lurasidone hydrochloride by LC-QTOF-MS techniques.
    Siddig O; Liu C; Abdulbagi M; Song M; Lu YT; Hang TJ
    J Pharm Biomed Anal; 2024 Jan; 238():115834. PubMed ID: 37948773
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization of degradation products of Macozinone by LC-MS/MS and elucidation of their degradation pathway.
    Guo K; Shan Y; Zhang T; Li G; Li P; Ma C
    J Pharm Biomed Anal; 2022 Sep; 219():114865. PubMed ID: 35716420
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Insights into the degradation chemistry of tazarotene, a third generation acetylenic retinoid: LC-HRMS (Orbitrap), LC-MS
    Singh DK; Sahu A; Balhara A; Giri S; Singh S
    J Pharm Biomed Anal; 2020 Jul; 186():113316. PubMed ID: 32413825
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Separation and characterization of forced degradation products in homoharringtonine injection by UHPLC-Q-TOF-MS.
    Gu X; Chen Y; Lou Y; Zheng J
    J Pharm Biomed Anal; 2019 Nov; 176():112801. PubMed ID: 31430625
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of degradation products of brivaracetam using liquid chromatography quadrupole time-of-flight tandem mass spectrometry: Degradation pathway elucidation.
    Xu K; Ning M; Li W; Dong H; Lu Y; Hang T; Song M
    Rapid Commun Mass Spectrom; 2024 Jan; 38(2):e9651. PubMed ID: 38124167
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of forced degradation products of tedizolid phosphate by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Lei Y; Jin B; Ma C; Zhang T; Li T
    J Pharm Biomed Anal; 2017 May; 139():221-231. PubMed ID: 28292681
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Liquid chromatography tandem mass spectrometric studies of indinavir sulphate and its forced degradation products.
    Rao RN; Vali RM; Raju SS
    J Pharm Biomed Anal; 2013 Feb; 74():101-10. PubMed ID: 23245240
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization of stress degradation products of fosinopril by using LC-MS/TOF, MS(n) and on-line H/D exchange.
    Narayanam M; Singh S
    J Pharm Biomed Anal; 2014 Apr; 92():135-43. PubMed ID: 24518132
    [TBL] [Abstract][Full Text] [Related]  

  • 76. LC-UV-PDA and LC-MS studies to characterize degradation products of glimepiride.
    Bansal G; Singh M; Jindal KC; Singh S
    J Pharm Biomed Anal; 2008 Nov; 48(3):788-95. PubMed ID: 18804934
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Proposal of degradation pathway with toxicity prediction for hydrolytic and photolytic degradation products of timolol.
    Devrukhakar PS; M SS; G S; R S
    J Pharm Biomed Anal; 2018 May; 154():7-15. PubMed ID: 29524771
    [TBL] [Abstract][Full Text] [Related]  

  • 78. LC-MS/MS characterization of forced degradation products of zofenopril.
    Ramesh T; Nageswara Rao P; Nageswara Rao R
    J Pharm Biomed Anal; 2014 Jan; 88():609-16. PubMed ID: 24211724
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterization of degradation products of idarubicin through LC-UV, MS(n) and LC-MS-TOF studies.
    Kaushik D; Bansal G
    J Pharm Biomed Anal; 2013 Nov; 85():123-31. PubMed ID: 23933565
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification and characterization of forced degradation products of 5-hydroxymethyl-2-furaldehyde (5-HMF) by HPLC, LC-LTQ/Orbitrap and NMR studies.
    Lu Y; Guo Y; Zhang Y; Sun H; Wu X
    J Pharm Biomed Anal; 2023 Sep; 233():115470. PubMed ID: 37210891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.